About this episode
This podcast explores the controversial potential untoward effects on cardiovascular health of xanthine oxidase inhibitors (often used for treatment of gout). The podcast takes a deep dive into the evidence to date, how to interpret it for frontline ambulatory pharmacists, and also previews studies to look out for in the near future. Presented by: Michael Nagy, PharmD, BCACPAssistant Professor, Medical College of Wisconsin School of PharmacyClinical Pharmacy Specialist – Zablocki VA Medical Center, Milwaukee, WI
